Do We Need Activity Scores or Simply Clear Criteria for Intestinal Ultrasound in Ulcerative Colitis? by T. Kucharzik et al.
Copyright © 2018 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved.  
For permissions, please email: journals.permissions@oup.com
1383
Journal of Crohn's and Colitis, 2018, 1383–1384
doi:10.1093/ecco-jcc/jjy167
Editorial
Editorial
Do We Need Activity Scores or Simply Clear Criteria for 
Intestinal Ultrasound in Ulcerative Colitis?
Torsten Kucharzika, Christian Maaserb, Giovanni Maconic
aKlinikum Lüneburg, Department of Gastroenterology, Lüneburg, Germany bKlinikum Lüneburg, IBD Outpatient 
Department, Lüneburg, Germany cL Sacco University Hospital, Department of Gastroenterology, Milan, Italy
*Corresponding author: Torsten Kucharzik, MD, PhD, Department of Gastroenterology, Lüneburg Hospital, Bögelstr. 1, 
Lüneburg, Germany. Tel: +49 4131 772241; Fax: +49 4131 772245; Email: Torsten.Kucharzik@klinkum-lueneburg.de
Non-invasive diagnostic tools are playing increasingly relevant roles 
in monitoring inflammatory bowel diseases. Increasing data sup-
port the view that intestinal ultrasound [IUS] can be used as a reli-
able tool to determine and to monitor Crohn’s disease activity.1–3 
Consequently, the use of IUS to follow up active Crohn’s disease is 
recommended in recent ECCO diagnostic guidelines.4 The role of 
IUS in ulcerative colitis [UC] is less well defined and fewer studies 
have determined its role in measuring disease activity.5–8
The study by M. Allocca et al. published in the current issue of 
JCC aims to develop an IUS score to assess disease activity and sever-
ity of UC using endoscopy as a comparator.
The key conclusions of the study are that colonic wall thickness 
[CWT] and vascularity of the colonic walls, namely colonic wall 
flow [CWF] as assessed by colour Doppler, were the most important 
features in assessing disease activity. In particular, the study showed 
that CWT > 3 mm coupled with CWF, or CWT as a single param-
eter, but with a cut-off of > 4.43 mm, indicates disease activity with 
Mayo sub-score of 2–3, with sensitivity of 0.71 and specificity of 
1.00. The single parameter of CWT > 3 mm gave better accuracy 
[0.88] with greatest sensitivity [0.89] and specificity [0.87]. Of Note, 
simple sonographic criteria (Humanitas ultrasonographic criteria 
[HUC]) showed high interobserver agreement with a kappa of 0.86. 
Receiver operating characteristic curve analysis identified a score 
≥ 6.3 as an indicator of endoscopic activity [Mayo sub-score ≥ 2], 
with a specificity of 100%. When the authors combine the HUC 
with faecal calprotectin [FC], the accuracy of HUC did not change 
significantly, suggesting that ultrasound parameters alone are suf-
ficient to determine endoscopic activity in UC.
This well-described trial underlines the role of IUS in determining 
disease activity in UC. It also strengthens the relevance of stand-
ardization of measurement of IUS findings as well as the require-
ment of developing IUS criteria for measuring disease activity in UC. 
Developing simple, statistically derived scores to determine disease 
activity as demonstrated in the current pilot study is a crucial step to 
standardize monitoring of the disease.
However, although these criteria are very simple and have an over-
all high specificity, they may miss the diagnosis of active inflammation 
in as many as three of ten patients, but are well in keeping with data in 
the literature. This result is expected given the typical mucosal damage 
associated with UC, but offers us the possibility to choose the best IUS 
criterion for individual patients. Among the criteria shown in the study, 
however, it appears that simply bowel wall thickening may provide the 
best performance in terms of sensitivity and specificity. However, the 
additional use of vascularization assessed with colour Doppler, or of 
inflammation by using FC, may increase the specificity or, conversely, 
the sensitivity, to exclude or confirm active inflammation.
The study also confirms the ease of detecting activity of UC by 
IUS, given that it may be simply revealed by an abnormal colonic 
wall thickening [>  3  mm]. In fact, it is well known from the lit-
erature data, recently summarized in the European Guidelines for 
Ultrasound in IBD, that bowel wall thickening > 3 mm is the cut-off 
to assess the presence of IBD, and active UC in particular,9 and that 
the detection of abnormal wall thickening [> 3 mm] is one of the 
most reproducible IUS parameters.10
Our own unpublished data suggest that measurement of CWT alone 
might be sufficient if CWT is determined in a standardized manner.
Although the current study could not show an additional effect of 
measuring FC, it is conceivable that a combination of IUS with FC may 
increase the accuracy in determining disease activity at least in a sub-
group of UC patients. Measurement of FC may in particular increase 
sensitivity in patients with active rectal inflammation, where IUS shows 
low sensitivity. Unfortunately, patients with UC limited to the rectum 
and distal sigmoid colon were excluded in Allocca’s study and therefore 
the accuracy reported in assessing activity in this study may not exactly 
reflect accuracy in the general UC population. Reduced sensitivity in 
patients with active disease limited to the mucosa without increased 
bowel wall thickening should also be taken into account. These false 
negatives harbour the risk of oversimplification with use of a score.
FC could therefore represent a valid tool in combination with 
IUS in general practice, but this remains to be demonstrated in future 
studies. Multicentre studies are therefore required to validate the 
HUC in larger cohorts and to evaluate its usefulness in monitor-
ing UC. In particular, it will be mandatory to perform more stud-
ies investigating the value of the different IUS parameters that are 
required to determine disease activity as well as studies that evaluate 
the role of IUS in measuring and monitoring disease activity in UC.
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It is unclear how many parameters are required to develop a sim-
ple and reliable score for monitoring disease activity. It remains also 
to be defined if we need a score that can simply discriminate active vs 
non-active disease, or another one that can provide different degrees 
of disease activity, such as currently offered by endoscopic evalu-
ation, which for this reason remains and will probably remain the 
reference standard for assessing UC activity.
However, preliminary data from a large multicentre trial in 
patients with active UC, whose disease activity has been moni-
tored by using IUS, showed promising results, revealing changes 
in bowel wall thickness by IUS as early as 2 weeks after treatment 
initiation.11 With more robust data showing the utility of IUS in 
monitoring disease activity in IBD, IUS may become a cost-effec-
tive, safe and easy to use diagnostic tool that might replace or at 
least reduce the number of invasive colonoscopies for monitoring 
disease activity.
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